All Companies

Companysort icon Description Status Initial Date
<a href="/venture-capital/all-companies/genomics-collaborative">Genomics Collaborative</a> Large repository of human DNA, serum and tissue samples linked to detailed clinical information Acquired 2000 View Profile
<a href="/venture-capital/all-companies/exact-sciences">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers Public 1995 View Profile
<a href="/venture-capital/all-companies/epitome-biosystems">Epitome Biosystems</a> Developing novel protein measurement systems based on Protien Epitope Tag technology Acquired 2003 View Profile
<a href="/venture-capital/all-companies/ensemble-therapeutics-corporation">Ensemble Therapeutics Corporation</a> Deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. Private 2004 View Profile
<a href="/venture-capital/all-companies/eleven-biotherapeutics-inc">Eleven Biotherapeutics, Inc.</a> Discovering and developing protein therapeutics to treat diseases of the eye. Public 2008 View Profile
<a href="/venture-capital/all-companies/editas-medicine">Editas Medicine</a> Unlocking the promise of genome editing to deliver life-changing medicines. Private 2013 View Profile
<a href="/venture-capital/all-companies/ecosense-lighting%C2%AE">EcoSense Lighting®</a> Providing best-in-class LED lighting solutions for use in architectural applications. Private 2013 View Profile
<a href="/venture-capital/all-companies/cytyc">CYTYC</a> Design, development, manufacturing, and marketing of medical devices focused on women's health Public 1989 View Profile
<a href="/venture-capital/all-companies/concert-pharmaceuticals-inc">Concert Pharmaceuticals, Inc.</a> Applying the company’s DCE Platform® (deuterated chemical entity platform) to create novel and differentiated small molecule drugs. Public 2006 View Profile
<a href="/venture-capital/all-companies/color-kinetics">Color Kinetics</a> Pioneer in the design, marketing and licensing of intelligent solid-state lighting systems Acquired 1997 View Profile
ChemGenics Pharmaceuticals Genetically directed drug discovery focused on fungal bacterial diseases Acquired 1992 View Profile
<a href="/venture-capital/all-companies/cgi-pharmaceuticals-inc">CGI Pharmaceuticals, Inc.</a> Developing small molecule therapeutics for multiple oncology and immunology-based indications Acquired 2001 View Profile
<a href="/venture-capital/all-companies/celexion-llc">Celexion LLC</a> Developing powerful platform technologies and products for partners in the pharmaceutical, industrial, agricultural, and consumer sectors. Private 2009 View Profile
<a href="/venture-capital/all-companies/celera">Celera</a> Sequenced human genome; now focused on therapeutics for cancer and other diseases Public 1998 View Profile
<a href="/venture-capital/all-companies/blend-therapeutics-inc">Blend Therapeutics Inc.</a> Discovering new classes of medicines that have unique modes of action to result in drugs with differentiated therapeutic properties. Private 2012 View Profile
<a href="/venture-capital/all-companies/black-duck-software-inc">Black Duck Software, Inc.</a> Providing the world’s only end-to-end platform for OSS Logistics. Private 2004 View Profile
<a href="/venture-capital/all-companies/bind-therapeutics-inc">BIND Therapeutics, Inc.</a> Developing Accurins, its novel targeted therapeutics. Public 2007 View Profile
<a href="/venture-capital/all-companies/bg-medicine-inc">BG Medicine, Inc.</a> Developing and delivering diagnostic solutions to aid in the clinical management of heart failure and related disorders. Public 2000 View Profile
<a href="/venture-capital/all-companies/aveo-pharmaceuticals-inc">AVEO Pharmaceuticals, Inc.</a> Discovering, developing and commercializing cancer therapeutics. Public 2003 View Profile
<a href="/venture-capital/all-companies/avedro-inc">Avedro, Inc.</a> Advancing the science and technology of corneal crosslinking and refractive correction. Private 2009 View Profile